0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cordycepin Alleviates Anterior Cruciate Ligament Transection (ACLT)-Induced Knee Osteoarthritis Through Regulating TGF-β Activity and Autophagy [Retraction]

      Drug Design, Development and Therapy

      Dove

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Tao XM, Liu PF, Gu HY, et al. Drug Des Devel Ther. 2020;14:2809–2817. The Editor-in-Chief and Publisher of Drug Design, Development and Therapy wish to retract the published article. The authors notified us of some potential image duplication in their article: Figure 1C Control (H&E) appears to be duplicated with Figure 2B Control (H&E) and Figure 4B Control (H&E) Figure 1C Sham (H&E) appears to be duplicated with Figure 2B Sham (H&E) Figure 1C Control (Alcian blue) appears to be duplicated with Figure 2B Control (Alcian blue) and Figure 4B Control (Alcian blue) Figure 1C Sham (Alcian blue) appears to be duplicated with Figure 2B Sham (Alcian blue) Figure 1C ACLT (H&E) appears to be duplicated with Figure 2B Sham (H&E), Figure 4B Sham (H&E) and Figure 5A Sham (H&E) Figure 1C ACLT (Alcian blue) appears to be duplicated with Figure 2B ACLT (Alcian blue), Figure 4B ACLT (Alcian blue) and Figure 5A ACLT (Alcian blue) Figure 2B COR-20+ACLT (H&E) appears to be duplicated with Figure 4B COR-20+ACLT (H&E) and Figure 5A COR-20+ACLT (H&E) Figure 2B COR-20+ACLT (Alcian blue) appears to be duplicated with Figure 4B COR-20+ACLT (Alcian blue) and Figure 5A COR-20+ACLT (Alcian blue) Figure 1C Control (H&E) appears to show partial overlap with Figure 1C Sham (H&E) and Figure 2B Sham (H&E) Figure 1C Control (Alcian blue) appears to show partial overlap with Figure 1C Sham (Alcian blue) and Figure 2B Sham (Alcian blue) Despite notifying the journal of some of the duplicated images the authors were unable to provide a satisfactory explanation for the extent of the duplication. The authors were also unable to provide the original western blot raw data for their study. The editor determined the findings of the study were no longer valid and requested for the article to be retracted. The authors wish to apologise for this error. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

          Related collections

          Author and article information

          Journal
          Drug Des Devel Ther
          Drug Des Devel Ther
          dddt
          dddt
          Drug Design, Development and Therapy
          Dove
          1177-8881
          07 October 2020
          2020
          07 October 2020
          : 14
          : 4133
          Article
          283594
          10.2147/DDDT.S283594
          7549409
          © 2020 Dove Medical Press.

          This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

          Page count
          Figures: 0, Pages: 1
          Categories
          Retraction

          Pharmacology & Pharmaceutical medicine

          Comments

          Comment on this article